US 11813316
Lentiviral vector for treating hemoglobin disorders
granted A61KA61K38/42A61K48/005
Quick answer
US patent 11813316 (Lentiviral vector for treating hemoglobin disorders) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/42, A61K48/005